Phase
Condition
Claudication
Peripheral Arterial Occlusive Disease
Intermittent Claudication
Treatment
pharmacological treatment
The BREATHER
Clinical Study ID
Ages 50-60 Male
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
sixty male patients with diagnosed with grade I and grade II COPD their ages rangedbetween 55-60years
All patients will be clinically and medically stable when attending the study.
Body mass index (BMI) is 18.5 to 24.9 kg/m2.
History of unilateral exertional leg pain,
Ambulation during a graded treadmill test limited by leg pain consistent withintermittent claudication (stage II of the fontaine classification of pad),
And an ankle-brachial index (ABI) of 0.90 or lower at rest or 0.73 or lower afterexercise.
Exclusion
Exclusion Criteria:
cardiovascular insufficiency,
Recent myocardial infarction,
heart failure,
arrhythmia,
DVT,
Intracranial hypertension,
Pneumonia,
kidney failure,
fractures,
uncooperative patients,
cognitive impairment preventing a patient from participation in exercises.
Study Design
Study Description
Connect with a study center
Faculty of Physical Therapy
Dokki,
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.